Healthcare Markets
Health care is bought and sold under strange conditions.
10 frameworks, from 1963 to today · Health Economics · Economics
- Information asymmetry and agency 1963-Present
- Insurance economics of moral hazard and adverse selection 1965-Present
- Supplier-induced demand 1970-1995
- Grossman model of health demand 1972-Present
- Managed competition 1978-Present
- Managed care 1980-2000
- Empirical industrial organization 1985-Present
- Risk adjustment 1990-Present
- Quasi-experiment 1995-Present
- Value-based payment 2000-Present
Overview
Health care is bought and sold under strange conditions1. The patient usually does not know what treatment he needs; the doctor both advises the purchase and supplies it; and a third party—an insurer or a government—often pays most of the bill1. Healthcare markets is the branch of health economics that studies how these peculiar exchanges work: how prices, quantities, quality, and risk are determined when information is lopsided and payment is pooled. Its history is a sequence of attempts to make ordinary economic tools fit a market where the buyer is often not the chooser, the seller often defines the need, and the product can be a matter of life and death.
The mid-twentieth-century puzzle: demand without a normal buyer
The founding problem was demand. In an ordinary market, a consumer who wants a good buys it. In medicine, the patient seeks care because he is ill, but the physician decides what care is needed1. Economists in the 1950s and 1960s therefore asked whether the standard theory of consumer demand could apply at all.
The most influential answer came from Kenneth Arrow's 1963 essay "Uncertainty and the Welfare Economics of Medical Care."1 Arrow argued that the defining feature of medical markets is uncertainty about when illness will strike and what treatment will work, combined with a deep information gap between physician and patient1. Because the patient cannot judge the quality of advice, he relies on trust and on professional norms; because illness is unpredictable, insurance arises to pool risk. Arrow's essay established the information asymmetry framing: the market for care is not a standard competitive market but one shaped by agency—the physician acts on the patient's behalf—and by the institutions, such as licensure and nonprofit hospitals, that societies build to manage that agency.
A parallel line of work asked why people demand health at all. Michael Grossman's 1972 model of health capital treated health as a durable stock that people invest in—through medical care, diet, exercise—and that depreciates with age. Health is not consumed for its own sake but as an input into producing healthy days. The model made a striking prediction: as people age, the cost of maintaining health rises, so they invest less and health declines; and higher wages raise the value of healthy time, so richer people invest more. This health capital framework turned the demand for care into a derived demand—derived from the demand for health itself—and gave economists a way to think about prevention, aging, and the returns to medical spending1.
Supplier-induced demand and the agency problem
If the physician decides what the patient needs, what stops the physician from recommending more care than necessary? This question produced the supplier-induced demand literature, developed most prominently by Victor Fuchs and by Robert Evans in the 1970s and 1980s. The claim was that physicians, facing a target income or responding to fee schedules, could shift the demand curve for their own services—recommending extra visits or tests that a fully informed patient would not choose. The evidence was contested: studies of fee changes and utilization produced mixed results, and critics argued that observed correlations could reflect unmeasured patient need. But the idea forced the field to take the agency relationship seriously as an economic problem, not merely an ethical one.
The policy implication was direct: how you pay the physician changes what he does. Fee-for-service rewards volume; capitation—a fixed payment per patient—rewards restraint but risks under-provision. This tension between moral hazard (once insured, people use more care because someone else pays) and supply-side incentives became the organizing axis of payment policy.
Insurance economics: moral hazard and adverse selection
Insurance itself became a central object of study. The moral hazard problem—the tendency of insured people to use more care because the marginal cost to them is low—was formalized in the 1960s and 1970s, and it received its most famous empirical test in the RAND Health Insurance Experiment (1974–1982), a randomized trial that assigned families to different cost-sharing plans. The finding that higher copayments reduced spending without large measured harms to health (except among the poorest and sickest) gave the field its benchmark estimate of demand response.
The second problem was adverse selection: if insurers charge a uniform premium, sicker people are more likely to buy generous coverage, driving up costs and pushing healthy people out12. This dynamic, analyzed in the classic insurance literature and applied to health by economists in the 1970s and 1980s, explained why markets for individual insurance can unravel and why employers and governments pool risk. The policy response—risk adjustment, paying insurers more for sicker enrollees—became a technical field of its own, with formulas that use diagnoses to predict costs. Risk adjustment is the regulatory answer to selection: it tries to make insurers compete on efficiency rather than on attracting the healthy.
Managed care and selective contracting
In the 1980s and 1990s, the American health system experimented with managed care: health maintenance organizations (HMOs) and preferred provider organizations that combined insurance with care management3. The economic logic was selective contracting—insurers negotiating discounted prices with chosen providers and steering patients toward them—and utilization review, which policed the physician's decisions3. Managed care did slow spending growth in the 1990s, but it provoked a backlash from patients and physicians who resented restrictions, and its market share and intensity waxed and waned.
The theoretical companion was managed competition, associated with Alain Enthoven in the late 1970s and 1980s: a framework in which competing insurers, regulated to prevent selection, would bargain with providers and compete for enrollees on price and quality. Managed competition shaped the design of the Dutch and Swiss insurance systems and, in a different form, the American Affordable Care Act's insurance marketplaces. Its central claim was that competition could be made to work if the rules forced insurers to bear the cost of their choices and prevented them from cherry-picking the healthy.
Empirical industrial organization: measuring market power and prices
From the 1980s onward, health economists increasingly borrowed the tools of empirical industrial organization—the branch of economics that estimates how firms compete, how prices are set, and how mergers affect consumers. In health care, this meant studying hospital competition, measuring the effect of concentration on prices, and estimating demand for insurance plans. The question was no longer only "what is the theory of the physician's behavior?" but "what do the data say about how much market power hospitals have, and what happens to prices when they merge?"
This empirical turn was accelerated by a methodological revolution. Quasi-experimental causal identification—using natural experiments, policy discontinuities, and instrumental variables to isolate causal effects—became the field's dominant style. The classic example is the work of Jonathan Gruber and others on the Oregon Health Insurance Experiment (a lottery that assigned Medicaid coverage) and on Massachusetts health reform, which used policy variation to estimate the effects of insurance on utilization and health. The same toolkit was applied to hospital mergers, payment reforms, and pharmaceutical pricing. The shift was from describing correlations to credibly estimating what caused what.
Value-based payment and the present
The most recent turn is value-based payment: paying providers for outcomes or quality rather than volume. Pay-for-performance schemes, accountable care organizations, and bundled payments all attempt to align the physician's financial incentive with the patient's interest. The evidence is mixed—many programs produce modest effects—but the idea has become central to policy debates in the United States, the United Kingdom, and elsewhere.
Today the field is a hybrid. It retains the Arrow–Grossman theoretical core: information asymmetry, agency, health capital, and insurance selection. It has absorbed the empirical industrial organization toolkit: structural estimation of demand and supply, merger analysis, and quasi-experimental evaluation. And it is increasingly concerned with the design of payment and regulation—risk adjustment, managed competition, value-based contracts—as the practical instruments for making a market with strange properties behave better. The open questions are the old ones in new form: how much care is induced by the supplier rather than needed by the patient; how to pool risk without destroying incentives; and whether competition among insurers and providers can be harnessed without sacrificing equity or quality.
References
- Health economics (introduction, Healthcare markets, History, Healthcare demand), Wikipedia
- Adverse selection, Wikipedia
- Managed care, Wikipedia
The frameworks of Healthcare Markets
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1963-Present
Information asymmetry and agency
How does lopsided information shape medical exchange?
- 1965-Present
Insurance economics of moral hazard and adverse selection
Why does insurance change what people buy and who buys it?
- 1970-1995
Supplier-induced demand
Do doctors create the demand for their own services?
- 1972-Present
Grossman model of health demand
Why do people invest in their own health?
- 1978-Present
Managed competition
Can regulated competition among insurers control costs?
- 1980-2000
- 1985-Present
Empirical industrial organization
How much market power do hospitals and insurers have?
- 1990-Present
- 1995-Present
- 2000-Present
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Supplier-induced demand influenced by Information asymmetry and agency
The supplier-induced demand literature grew directly out of Arrow's agency framing: if the physician advises and supplies care under asymmetric information, the question becomes whether the physician can shift demand for his own services.
Carried by Victor Fuchs; Robert Evans.
Risk adjustment grew out of Insurance economics of moral hazard and adverse selection
Risk adjustment is the regulatory answer to adverse selection: formulas that pay insurers more for sicker enrollees were developed to stop the selection spiral that the insurance economics literature had analyzed.
Insurance economics of moral hazard and adverse selection influenced by Information asymmetry and agency
Arrow's 1963 essay framed medical care as shaped by uncertainty and information gaps, and the insurance literature that followed took up his point that risk pooling is the market's response to that uncertainty, formalizing moral hazard and adverse selection in health insurance.
Carried by Kenneth Arrow; Uncertainty and the Welfare Economics of Medical Care (1963).
Managed competition influenced by Insurance economics of moral hazard and adverse selection
Managed competition took from insurance economics the problem of adverse selection and built its rules around preventing insurers from cherry-picking the healthy.
Carried by Alain Enthoven.
Managed care influenced by Insurance economics of moral hazard and adverse selection
Managed care combined insurance with care management as a response to moral hazard, using utilization review and selective contracting to control the extra use that insurance induces.
Managed care influenced by Supplier-induced demand
Managed care's utilization review and capitation were practical responses to the supplier-induced demand problem: policing the physician's decisions and changing payment to remove the reward for volume.
Managed care rival of Managed competition
Managed competition and managed care were contemporary answers to the same question of how to organize insurance and provider payment, one relying on regulated insurer competition and the other on direct care management by insurers.
Carried by Alain Enthoven.
Risk adjustment influenced by Managed competition
Managed competition required risk adjustment to make insurer competition work without selection, so the risk adjustment field developed as the technical instrument for that regulatory design.
Carried by Alain Enthoven.
Value-based payment influenced by Managed care
Value-based payment carried forward managed care's project of aligning provider incentives with cost and quality, replacing utilization review with pay-for-performance and bundled payments.
Beyond the field
Where Healthcare Markets's ideas came from in other fields, and what they led to there: the strongest 12 of 34 links.
Grossman model of health demand grew out of Human capital in Health Capital And Demand For Health
Grossman's 1972 model of health demand is a direct extension of human-capital theory, treating health as a durable capital stock that yields healthy time. He built explicitly on Becker's human-capital framework.
Carried by Michael Grossman; Gary Becker.
Grossman model of health demand led to Structural Life-Cycle Modeling in Health Capital And Demand For Health
Structural life-cycle models of health insurance and medical spending derive from the Grossman demand-for-health framework, adding dynamic saving and insurance choice to Grossman's health capital model.
Carried by Michael Grossman.
Information asymmetry and agency influenced Market Failure and Adverse Selection in Social Insurance And Redistribution
Arrow's 1963 paper identified adverse selection and moral hazard as reasons medical insurance markets fail, feeding the market-failure literature on adverse selection. That literature built directly on his account of information problems in insurance.
Carried by Kenneth Arrow.
Information asymmetry and agency influenced Principal–agent problem in Personnel Economics
Kenneth Arrow's 1963 work on information asymmetry in medical care established the informational problems that later principal-agent models formalized. The agency literature in healthcare built on Arrow's framing of asymmetric information between patient and provider.
Carried by Kenneth Arrow; Uncertainty and the Welfare Economics of Medical Care (1963).
Information asymmetry and agency influenced Adverse selection in Information Economics
Arrow's work on information asymmetry and agency in medical care applied the emerging adverse-selection and moral-hazard analysis to physician and patient behaviour. The healthcare-markets literature took its hidden-information framework from this source.
Carried by Kenneth Arrow; Uncertainty and the Welfare Economics of Medical Care (1963).
Information asymmetry and agency influenced by Health Insurance and Welfare Economics in Health Economics
Arrow's 1963 paper was written as a contribution to welfare economics, applying the tools of that tradition to medical care and insurance. The health-insurance-and-welfare-economics line took up his framing of insurance and risk allocation as welfare problems.
Carried by Kenneth Arrow.
Information asymmetry and agency influenced by Arrow–Debreu Model in General Equilibrium
Arrow's 1963 paper explicitly framed medical care against the Arrow–Debreu general-equilibrium benchmark, showing where information and uncertainty break its assumptions. The health-care framework is defined by contrast with that model.
Carried by Kenneth Arrow.
Information asymmetry and agency influenced Asymmetric Information and Market Failure in Information Economics
Arrow's analysis of information asymmetry and agency in healthcare supplied a central case in which asymmetric information produces market failure, which the later general literature cited and generalised. The healthcare work is an earlier application that fed the broader framework.
Carried by Kenneth Arrow; Uncertainty and the Welfare Economics of Medical Care (1963).
Information asymmetry and agency influenced Adverse selection in Insurance Theory
Arrow's 1963 paper on uncertainty in medical care introduced information asymmetry between physician and patient and insurer, the setting in which adverse selection was later modelled. The information-asymmetry and agency literature carried that problem into formal selection theory.
Carried by Kenneth Arrow.
Information asymmetry and agency influenced Supplier-induced demand in Payment And Incentives
Information asymmetry and agency theory gave supplier-induced demand its explanatory mechanism: the physician as imperfect agent of the patient. The SID literature explicitly rests on this agency asymmetry.
Carried by Kenneth Arrow.
Insurance economics of moral hazard and adverse selection influenced Cyber insurance in Security Economics
The insurance economics of moral hazard and adverse selection, developed for health and other insurance markets, provides the analytical template for cyber insurance: asymmetric information about security posture drives adverse selection, and coverage weakens incentives to secure systems. Cyber insurance research explicitly imports these selection and incentive problems.
Insurance economics of moral hazard and adverse selection influenced by Adverse selection in Information Economics
The insurance economics of moral hazard and adverse selection took the Rothschild-Stiglitz screening model as its core account of how insurers separate risk types. That model is the same adverse-selection analysis applied to health and other insurance markets.
Carried by Michael Rothschild; Joseph Stiglitz; Equilibrium in Competitive Insurance Markets (1976).

Healthcare Markets is a planet in Nousfarer
Its city has a tower for each of these 10 frameworks. Land, walk in, and climb one concept at a time.
Land on Healthcare MarketsRelated fields
Fields its ideas are linked to
- Health Insurance 6 links
- Payment And Incentives 4 links
- Health Capital And Demand For Health 3 links
- Health Economics 3 links
- Information Economics 3 links
- Insurance Theory 2 links
- Care Delivery Models 2 links
- Social Insurance And Redistribution 2 links
- Econometrics 1 link
- Pharmaceutical Economics 1 link
- Life And Health Insurance 1 link
- Personnel Economics 1 link
More in Health Economics
- Health Capital And Demand For Health
- Health Economics
- Health Insurance
- Health Policy Evaluation
- Health Technology Assessment
- Pharmaceutical Economics
See where Healthcare Markets sits on the Map of Human Knowledge